US 11,787,834 B2
Glucocorticoid receptor agonists
Adel Ahmed Rashad Ahmed, Fishers, IN (US); Joshua Ryan Clayton, Fishers, IN (US); Jose Eduardo Lopez, Fishers, IN (US); William Thomas McMillen, Indianapolis, IN (US); Ryan Edward Stites, Indianapolis, IN (US); Takako Wilson, Indianapolis, IN (US); and Jacqueline Mary Wurst, Indianapolis, IN (US)
Assigned to Eli Lilly and Company, Indianapolis, IN (US)
Filed by Eli Lilly and Company, Indianapolis, IN (US)
Filed on Mar. 22, 2022, as Appl. No. 17/700,943.
Claims priority of provisional application 63/164,613, filed on Mar. 23, 2021.
Claims priority of provisional application 63/260,451, filed on Aug. 20, 2021.
Prior Publication US 2022/0324904 A1, Oct. 13, 2022
Int. Cl. C07J 71/00 (2006.01)
CPC C07J 71/0031 (2013.01) 7 Claims
 
1. A compound, wherein the compound is:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.